SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-059415
Filing Date
2023-11-06
Accepted
2023-11-06 16:20:24
Documents
50
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q oric-20230930.htm   iXBRL 10-Q 2587321
2 EX-31.1 oric-ex31_1.htm EX-31.1 18598
3 EX-31.2 oric-ex31_2.htm EX-31.2 18582
4 EX-32.1 oric-ex32_1.htm EX-32.1 10463
5 EX-32.2 oric-ex32_2.htm EX-32.2 10409
  Complete submission text file 0000950170-23-059415.txt   7608717

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT oric-20230930_cal.xml EX-101.CAL 31342
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oric-20230930_lab.xml EX-101.LAB 359463
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oric-20230930.xsd EX-101.SCH 37497
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT oric-20230930_def.xml EX-101.DEF 135195
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oric-20230930_pre.xml EX-101.PRE 247442
44 EXTRACTED XBRL INSTANCE DOCUMENT oric-20230930_htm.xml XML 1308005
Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Filer) CIK: 0001796280 (see all company filings)

IRS No.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39269 | Film No.: 231380240
SIC: 2834 Pharmaceutical Preparations